1[1]Yonson K, Takumi F, Takeshi I, et al.Clinical pilot study on high-d ose intruaarterial hemotherapy with direct hemoperfusion under hepatic venous is olation in patients with advanced hepatocellular cinoma.Surgey, 1995, 117:510- 519.
2[2]Yonson K, Takumi F, Masahiro T, et al. Single catheter technique of hepati c venous isolation and extraco-rpeal charcoal hemoperfusion for malignant liver tumors. The American of Surgeon, 1997, 173:103-109.
3[3]Takeshi I, Yonson K, Nobuy K, et al. Regional pharmacokinetics of doxorubi cin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charncoal hemoperfusion.Cance Resarch, 1998, 58:3 339-3343.
4[4]Marc G, Van L, Joost R, et al. Isolated hypoxic hepatic perfusion with tum or necosis factor-a, melphalan, and mitomycin cusing ballon catheter technique s.Annals of Surgeon, 1998, 228:763.770.
5[5]Takatsuga Y, Michiyosi, Yoshiyaki N, et al. The serum interleukin-8 level reflects hepatic mitochondrial redox state in hyperthermohypoxic isolated liver perfusion with use of a venous bypass.Surgeon, 1999, 125:304-314.
6[6]Alexander HR JR, Bartler DL, Libuttisk, et al.Isolated hepatic perfusion wi th tumor necrosis factor and melphalan for unresectable cancer confined to the l iver.Journal of Clinical Oncology, 1998, 16:1479-1489.
7[7]Vahrmeijer AL, Vanaerebb MM, Dierendonck V, et al.Delivery of anitcanc er drugs via isolated hepatic perfusion: a promising strategy in the treatment o f irresctable liver metastases? Semin Surg Oncol, 1998, 14:262-268.
8[8]Ku Y, Tominaga M, Iwasaki T, et al.The long-term results of percutaneous isolated hepatic perfusion for patients with advanced hepatocellular carcinoma. Gan To Kagaku Ryoho, 1998, 25:1266-1268.
9[9]Oldhafer KJ, Frerker MK, Lang H, et al.High-dose mitomycinc in isolated hyperthermic liver perfusion for unresectable lever metastases.J Invest Surg, 1 998, 116:383-400.
